Clearline Capital’s Achieve Life Sciences QUIT Stock Holding History
Bought
Maintained
Sold
Other funds holding QUIT
Clearline Capital's QUIT Position: Q4 2025 in Review
Clearline Capital sold out of Achieve Life Sciences (QUIT) in Q4 2025, closing a stake of 451,219 shares — an estimated $1.42M sold.
Clearline Capital first reported a position in QUIT in Q2 2021 and held it in 9 quarters. The position peaked at $3M in Q2 2025. 78 funds tracked by Wall St. Rank hold QUIT as of Q4 2025.
- Clearline Capital reported no remaining Achieve Life Sciences position as of Q4 2025 after selling out during the quarter.
- Clearline Capital sold 451,219 Achieve Life Sciences shares in Q4 2025, an estimated $1.42M.
- Clearline Capital first reported a position in Achieve Life Sciences in Q2 2021 and held it in 9 quarters.
- Clearline Capital's Achieve Life Sciences position peaked at $3M in Q2 2025.
- 78 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q4 2025.
Based on Clearline Capital's 13F filing for Q4 2025, filed 17 Feb 2026.